Cite
SARS-CoV-2 Inactivated Vaccine in Naïve ANCA-Associated Vasculitis: Impact of Glucocorticoid Use
MLA
Rosa Maria Rodrigues Pereira, et al. “SARS-CoV-2 Inactivated Vaccine in Naïve ANCA-Associated Vasculitis: Impact of Glucocorticoid Use.” SSRN Electronic Journal, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........17dc1e4dbc16e71fdf37a13871232c9d&authtype=sso&custid=ns315887.
APA
Rosa Maria Rodrigues Pereira, Marilia A. Dagostin, Valeria F. Caparbo, Lucas P. Sales, Sandra Gofinet Pasoto, Clovis Artur Silva, Emily Figueiredo Neves Yuki, Carla G. S. Saad, Ana C. Medeiros-Ribeiro, Leonard Vinci Kanda Kupa, Solange R. G. Fusco, Victor A. O. Martins, Carolina T. Ribeiro, Carmen Valente Barbas, Samuel Katsuyuki Shinjo, Nádia Emi Aikawa, & Eloisa Silva Dutra de Oliveira Bonfa. (2022). SARS-CoV-2 Inactivated Vaccine in Naïve ANCA-Associated Vasculitis: Impact of Glucocorticoid Use. SSRN Electronic Journal.
Chicago
Rosa Maria Rodrigues Pereira, Marilia A. Dagostin, Valeria F. Caparbo, Lucas P. Sales, Sandra Gofinet Pasoto, Clovis Artur Silva, Emily Figueiredo Neves Yuki, et al. 2022. “SARS-CoV-2 Inactivated Vaccine in Naïve ANCA-Associated Vasculitis: Impact of Glucocorticoid Use.” SSRN Electronic Journal, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........17dc1e4dbc16e71fdf37a13871232c9d&authtype=sso&custid=ns315887.